Sunday, November 24, 2024

Life Sciences

ProPhase
ProPhase Labs, Inc., a biopharma, genomics, and diagnostics Company, announced an innovative step forward in cancer treatment research with the introduction of Project ZenQ-AI. This project employs the Company’s state-of-the-art AI platform which was meticulously developed with leading AI technology platforms and systems. The Company is harnessing its extensive...
TetraScience
TetraScience, the Scientific Data and AI Cloud company, announced a strategic partnership with Google Cloud at the Bio-IT World Conference & Expo to speed up drug development and other scientific discoveries. By bringing the Tetra Scientific Data and AI Cloud together with Google Cloud’s infrastructure and AI technologies, the...
Ezra
Ezra, the healthcare AI startup transforming early cancer detection through full body MRI screening, announced a partnership with RAYUS Radiology, a leading provider of imaging services. The partnership will enable Ezra to expand nationally in 150 RAYUS locations across the U.S. Ezra utilizes medical imaging and Artificial Intelligence to monitor...
Expert
Expert.ai, the industry leader in providing AI-powered language solutions to enterprises, announced the launch of the expert.ai Insight Engine for Life Sciences. For the world of drug research and development, data is both a challenge to be managed and an opportunity to be leveraged. The ability to effectively and quickly...
New England Biolabs announces the release of its Monarch Mag Viral DNA/RNA Extraction Kit. This extraction kit enhances recovery of low amounts of viral nucleic acid to enable highly sensitive detection. The kit uses a magnetic bead-based process to extract viral RNA and DNA reproducibly and efficiently, while enabling...
Roche
Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed in collaboration with Eli Lilly and Company, will be used to help identify the presence or absence of amyloid pathology in individuals, which...
Charles River
Charles River Laboratories International, Inc. announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex, an innovator in pathology AI. By combining Deciphex’s unique digital pathology solutions with Charles River’s robust non-clinical pathology programs, clients of both organizations will have...
Prenosis
Prenosis will collaborate with Roche to bring the Sepsis ImmunoScore™ to hospitals across the United States on Roche's navify® Algorithm Suite platform Prenosis, Inc., an artificial intelligence company enabling precision medicine in acute care, announced a commercial distribution collaboration with Roche for its Sepsis ImmunoScore™, an artificial intelligence/machine learning software as a medical device (AI...
PredxBio
PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital pathology firm pioneering AI-powered virtual staining technology, are pleased to announce a transformative partnership aimed at revolutionizing cancer research, diagnosis, and treatment. PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital...
InfoBionic.Ai
InfoBionic.Ai continues to advance its mission of improving outcomes and enabling better cardiac care with a name that captures the essence of its next gen, AI-enabled virtual telemetry solution. InfoBionic.Ai, a digital health company providing AI-powered diagnostic remote patient monitoring solutions, announced that it has evolved its company name from...